Li Wang

Doctoral Degree

兰州大学

Personal Information

Gender:Female
E-Mail:wang_li@dlut.edu.cn

VIEW MORE
Home > Scientific Research > Paper Publications

Improvement of chemosensitivity and inhibition of migration via targeting tumor epithelial-to-mesenchymal transition cells by ADH-1-modified liposomes.

Date of Publication:2018-11-01 Hits:

Indexed by:期刊论文
Date of Publication:2018-11-01
Journal:Drug delivery
Included Journals:SCIE、PubMed
Volume:25
Issue:1
Page Number:112-121
ISSN No.:1521-0464
Key Words:Chemoresistance,delivery,liposomes,migration,targeting
Abstract:How to overcome drug resistance and prevent tumor metastasis is key to the success of malignant tumor therapy. In this paper, ADH-1 peptide-modified liposomes (A-LP) have been successfully constructed for restoring chemosensitivity and suppressing cancer cell migration. With a particle size of about 90nm, this functionalized nanocarrier was loaded with fluorescent probe or paclitaxel (PTX). Cellular uptake studies showed that A-LP facilitated the delivery of anticancer drug to tumor cells undergoing EMT. Interestingly, this nanocarrier enhanced chemosensitivity by assessing the cell activity using CCK-8 assay. Further, the results of Wound scratch assay and Transwell migration assay showed the inhibition effect of this nanocarrier on tumor cell migration. Moreover, this nanocarrier exhibited significant tumor-targeting ability and anti-tumor efficacy in vivo. Collectively, A-LP might be a novel targeted drug delivery system to enhance the efficacy of chemotherapy and prevent tumor metastasis.